"Potential health benefits of lunasin: a multifaceted soy-derived bioactive peptide". (Q34460000)

2 August 2017

1 reference

title

"Potential health benefits of lunasin: a multifaceted soy-derived bioactive peptide". (English)

1 reference

2 August 2017

Vaibhao Kisanrao Lule

1

1 reference

2 August 2017

Sheenam Garg

2

1 reference

2 August 2017

Sarang Dilip Pophaly

3

1 reference

2 August 2017

Hitesh

4

1 reference

2 August 2017

Sudhir Kumar Tomar

5

1 reference

2 August 2017

27 January 2015

1 reference

2 August 2017

Journal of Food Science

1 reference

2 August 2017

80

1 reference

2 August 2017

3

1 reference

2 August 2017

R485-94

1 reference

Phyto-oestrogens and Western diseases

2 August 2017

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Pathways connecting inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Meta-analysis of the effects of soy protein intake on serum lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

RGD-peptide lunasin inhibits Akt-mediated NF-κB activation in human macrophages through interaction with the αVβ3 integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Soypeptide lunasin in cytokine immunotherapy for lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Effect of intact and isoflavone-depleted soy protein on NMU-induced rat mammary tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Lunasin induces apoptosis and modifies the expression of genes associated with extracellular matrix and cell adhesion in human metastatic colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Lunasin potentiates the effect of oxaliplatin preventing outgrowth of colon cancer metastasis, binds to α5β1 integrin and suppresses FAK/ERK/NF-κB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Differential gene expression of RAW 264.7 macrophages in response to the RGD peptide lunasin with and without lipopolysaccharide stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Lunasin promotes apoptosis in human colon cancer cells by mitochondrial pathway activation and induction of nuclear clusterin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Bowman-Birk inhibitor and genistein among soy compounds that synergistically inhibit nitric oxide and prostaglandin E2 pathways in lipopolysaccharide-induced macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Presence of lunasin in plasma of men after soy protein consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Lunasin in wheat: a chemical and molecular study on its presence or absence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

A soybean cDNA encoding a chromatin-binding peptide inhibits mitosis of mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Antioxidant activity and protective effects of peptide lunasin against oxidative stress in intestinal Caco-2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Lunasin and lunasin-like peptides inhibit inflammation through suppression of NF-kappaB pathway in the macrophage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Lunasin concentration in different soybean genotypes, commercial soy protein, and isoflavone products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Lunasin, with an arginine-glycine-aspartic acid motif, causes apoptosis to L1210 leukemia cells by activation of caspase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Lunasin, a novel seed peptide for cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Antioxidant and anti-inflammatory properties of cancer preventive peptide lunasin in RAW 264.7 macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Relationship between lunasin's sequence and its inhibitory activity of histones H3 and H4 acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Dynamics of keratinocytes in vivo using HO labeling: a sensitive marker of epidermal proliferation state

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Lunasin, a novel seed peptide, sensitizes human breast cancer MDA-MB-231 cells to aspirin-arrested cell cycle and induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Complementary roles in cancer prevention: protease inhibitor makes the cancer preventive peptide lunasin bioavailable

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Barley lunasin suppresses ras-induced colony formation and inhibits core histone acetylation in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Characterization of lunasin isolated from soybean

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

The cancer preventive peptide lunasin from wheat inhibits core histone acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Cancer-preventive peptide lunasin from Solanum nigrum L. inhibits acetylation of core histones H3 and H4 and phosphorylation of retinoblastoma protein (Rb).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Inhibition of core histone acetylation by the cancer preventive peptide lunasin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

The cancer preventive seed peptide lunasin from rye is bioavailable and bioactive

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Lunasin peptide purified from Solanum nigrum L. protects DNA from oxidative damage by suppressing the generation of hydroxyl radical via blocking fenton reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Understanding Lunasin's biology and potential as a cancer therapeutic by utilizing Drosophila genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Lunasin: attenuating effects on tumour growth in systemic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Cancer chemoprevention through dietary antioxidants: progress and promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Oxidative metabolism of the soy isoflavones daidzein and genistein in humans in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Infections as a major preventable cause of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Recombinant production of the therapeutic peptide lunasin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Lunasin suppresses E1A-mediated transformation of mammalian cells but does not inhibit growth of immortalized and established cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Recombinant expression of bioactive peptide lunasin in Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

The biochemical and functional food properties of the bowman-birk inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Lunasin: a cancer-preventive soy peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Health benefits of soy isoflavonoids and strategies for enhancement: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Lunasin in cereal seeds: What is the origin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Soybean foods and their benefits: potential mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Contents and bioactivities of lunasin, bowman-birk inhibitor, and isoflavones in soybean seed

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

In vitro digestibility of the cancer-preventive soy peptides lunasin and BBI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Effects of dietary intake of soy protein and isoflavones on cardiovascular disease risk factors in high risk, middle-aged men in Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Scalable purification and characterization of the anticancer lunasin peptide from soybean

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Efficient production of native lunasin with correct N-terminal processing by using the pH-induced self-cleavable Ssp DnaB mini-intein system in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Bioactive peptides in amaranth (Amaranthus hypochondriacus) seed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Soybean protein diet and plasma cholesterol: from therapy to molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Dietary soy-derived isoflavone phytoestrogens. Could they have a role in coronary heart disease prevention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

New mechanisms and therapeutic potential of curcumin for colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Soy protein reduces triglyceride levels and triglyceride fatty acid fractional synthesis rate in hypercholesterolemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

Soy, isoflavones, and breast cancer risk in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

In vitro chemo-protective effect of bioactive peptide lunasin against oxidative stress in human HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1750-3841.12786

21 January 2018

Identifiers

DOI

10.1111/1750-3841.12786

1 reference

2 August 2017

1 reference